Glycosphingolipidoses: Beyond the enzymatic defect: SPECIAL SECTION: Glyconeurobiology

By Raas-Rothschild Annick   Pankova-Kholmyansky Irene   Kacher Yaacov   Futerman Anthony H.  

Glycoconjugate Journal, Vol. 21, Iss. 6, 2004-01 ,pp. : 295-304

Springer Publishing Company

Access to resources Recommend Favorite

A turn in the road: How studies on the pharmacology of glucosylceramide synthase inhibitors led to the identification of a lysosomal phospholipase A₂ with ceramide transacylase activity

By Shayman James   Abe Akira   Hiraoka Miki  

Glycoconjugate Journal, Vol. 20, Iss. 1, 2003-02 ,pp. : 25-32

Springer Publishing Company

Access to resources Recommend Favorite

Bioabatement to Remove Inhibitors from Biomass-Derived Sugar Hydrolysates

By Nichols Nancy N.   Dien Bruce S.   Guisado Gema M.   López Maria J.  

Applied Biochemistry and Biotechnology, Vol. 121, Iss. 1-3, 2005-04 ,pp. : 379-390

Humana Press, Inc

Access to resources Recommend Favorite

Computer-aided discovery of novel non-peptide inhibitors against amyloid-beta (Aβ) peptide aggregation for treating Alzheimer's disease

By Zhou Zheng-Li   Ho Yih   Liu Hsuan-Liang   Elumalai Pavadai   Chen Wei-Hsi  

Molecular Simulation, Vol. 41, Iss. 8, 2015-05 ,pp. : 622-632

Taylor & Francis Ltd

Access to resources Recommend Favorite

Synthesis of Aldehydo-sugar Derivatives of Pyrazoloquinoline as Inhibitors of Herpes Simplex Virus Type 1 Replication

By Bekhit Adnan A.   El-Sayed Ola A.   Aboul-Enein Hassan Y.   Siddiqui Yunus M.   Al-Ahdal Mohammed N.  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 19, Iss. 1, 2004-02 ,pp. : 33-38

Informa Healthcare

Access to resources Recommend Favorite